Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
about
Stromal Targets for Fluorescent-Guided Oncologic SurgeryUrokinase receptor and resistance to targeted anticancer agentsSelecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsTumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis.uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.Human mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture models
P2860
Q26774497-04679F19-ABA5-4049-9976-4531AA726521Q26797385-9D625667-368D-427F-BFB1-DE25823BECD3Q28077999-036C9E65-5A04-4458-A855-65906BFD350AQ33703133-EDD581F0-C8D2-49D4-9D14-5F0ED91FDEA4Q33709060-66521B2B-5AC2-46DD-8FB4-C8E34E93593CQ35097486-8A992D94-A01C-4E0C-AFCD-7017E7121D97Q35781008-17B57DCC-0EFC-4FEF-AE2C-304EC28CA14EQ35987322-6BB41E6B-F461-4F50-9D13-589389DE38BAQ36568335-F43D2AA4-FCA9-4BF2-ADD9-1A7ACCC9F60CQ38555225-1213C89E-427A-4072-ADED-31E8C1D79F0AQ38692304-926C0926-8A51-4E0C-89FF-A36748B52C6DQ39424309-11833006-11F1-40AC-B395-43DECD3EBB69Q41542151-3ED7F6CA-D788-4E10-9126-61EF298A3B80Q58129602-C9B448C9-45BC-4DC1-B95A-CB85BCE39C9E
P2860
Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@ast
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@en
type
label
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@ast
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@en
prefLabel
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@ast
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@en
P2093
P2860
P356
P1433
P1476
Expression of uPAR in tumor-as ...... patient prognosis: a TMA study
@en
P2093
Alexander L Vahrmeijer
Andrew P Mazar
Cornelis J H van de Velde
Floris P R Verbeek
Hendrica A J M Prevoo
Martin C Boonstra
P2860
P2888
P356
10.1186/1471-2407-14-269
P407
P577
2014-04-17T00:00:00Z
P5875
P6179
1030066314